We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of BEAT yet.

BEAT Hedge Fund Activity: Q2 2021 in Review

0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q2 2021, worth a combined $0 — down 100% from $116K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BEAT and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Logan Capital Management, exiting entirely with an estimated $116K sold.

  • 0 institutional investors held BioTelemetry, Inc. (BEAT) as of Q2 2021, down from 1 in Q1 2021.
  • Funds reported $0 of BioTelemetry, Inc. stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new BioTelemetry, Inc. positions in Q2 2021 and 1 closed out, a net change of -1 holder.
  • The largest BioTelemetry, Inc. seller in Q2 2021 was Logan Capital Management, an estimated $116K sold.

Based on aggregated 13F filings for Q2 2021.